Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 643,675 shares, a drop of 92.1% from the August 15th total of 8,112,226 shares. Approximately 22.8% of the company’s stock are short sold. Based on an average trading volume of 927,244 shares, the days-to-cover ratio is currently 0.7 days.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on GRML shares. Wall Street Zen raised shares of Greenland Mines Ltd. Common Stock to a “sell” rating in a report on Saturday, August 29th. Weiss Ratings downgraded Greenland Mines Ltd. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Greenland Mines Ltd. Common Stock currently has an average rating of “Sell”.
Check Out Our Latest Stock Report on Greenland Mines Ltd. Common Stock
Greenland Mines Ltd. Common Stock Price Performance
Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) last released its quarterly earnings data on Monday, August 17th. The company reported ($0.03) EPS for the quarter.
Insider Buying and Selling at Greenland Mines Ltd. Common Stock
In related news, Director Jason David Sawyer purchased 4,800 shares of the business’s stock in a transaction dated Wednesday, July 22nd. The shares were acquired at an average cost of $11.50 per share, for a total transaction of $55,200.00. Following the acquisition, the director owned 4,800 shares of the company’s stock, valued at $55,200. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Riad Hussein El-Dada sold 3,500 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $11.50, for a total value of $40,250.00. Following the completion of the transaction, the director directly owned 3,500 shares of the company’s stock, valued at approximately $40,250. The trade was a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 11.30% of the company’s stock.
Institutional Trading of Greenland Mines Ltd. Common Stock
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Citadel Advisors LLC purchased a new stake in shares of Greenland Mines Ltd. Common Stock during the 2nd quarter worth about $1,343,000. Geode Capital Management LLC increased its stake in shares of Greenland Mines Ltd. Common Stock by 51.8% in the 4th quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after purchasing an additional 167,905 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Greenland Mines Ltd. Common Stock in the 4th quarter worth about $126,000. Jane Street Group LLC acquired a new position in shares of Greenland Mines Ltd. Common Stock during the 4th quarter worth approximately $64,000. Finally, XTX Topco Ltd raised its position in Greenland Mines Ltd. Common Stock by 101.2% during the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock worth $46,000 after acquiring an additional 80,768 shares during the period. Institutional investors and hedge funds own 20.07% of the company’s stock.
About Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Greenland Mines Ltd. Common Stock
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Greenland Mines Ltd. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenland Mines Ltd. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
